Correction to: Design, Synthesis, Radiolabeling, and Biologic Evaluation of Three 18F-FDG-Radiolabeled Targeting Peptides for the Imaging of Apoptosis, by Khoshbakht S, Beiki D, Geramifar P, et al. Cancer Biother Radiopharm 2019;34(5):271–279. DOI: 10.1089/cbr.2018.2709
Correction to: Design, Synthesis, Radiolabeling, and Biologic Evaluation of Three...
2019-08-01 00:00:00
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngCancer Biotherapy & RadiopharmaceuticalsUnpaywallhttp://www.deepdyve.com/lp/unpaywall/correction-to-design-synthesis-radiolabeling-and-biologic-evaluation-e0V0Qq1CdN
Correction to: Design, Synthesis, Radiolabeling, and Biologic Evaluation of Three 18F-FDG-Radiolabeled Targeting Peptides for the Imaging of Apoptosis, by Khoshbakht S, Beiki D, Geramifar P, et al. Cancer Biother Radiopharm 2019;34(5):271–279. DOI: 10.1089/cbr.2018.2709
Cancer Biotherapy & Radiopharmaceuticals
– Aug 1, 2019
Correction to: Design, Synthesis, Radiolabeling, and Biologic Evaluation of Three 18F-FDG-Radiolabeled Targeting Peptides for the Imaging of Apoptosis, by Khoshbakht S, Beiki D, Geramifar P, et al. Cancer Biother Radiopharm 2019;34(5):271–279. DOI: 10.1089/cbr.2018.2709
Cancer Biotherapy & Radiopharmaceuticals
– Aug 1, 2019
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.